title: AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
abstract: p97/VCP, a member of the AAA-ATPase super family, has been associated with a wide variety of essential cellular protein pathways com prising: (i) nuclear envelope reconstruction, (ii) cell cycle, (iii) Golgi reassembly, (iv) suppression of apoptosis and (v) DNA-damage response [1-6]. In addition, vasolin-containing protein (VCP) dislodges the ubiquitinated proteins from the endoplasmic reticulum (ER) and chaperones them to the cytosol for proteasomal degradation by endoplasmic reticulum-associated degradation (ERAD) [7]. The interactions of VCP in the endoplasmic reticulum-associated degradation (ERAD) pathway determine the substrate selection for proteasomal degradation. Moreover, the interaction with VCP is also required for the ubiquitination of substrate. VCP is phosphorylated by the master cellular kinase, Akt as a mechanism to regulate ERAD [8]. These multiple interactions in protein degradation pathways points to central role of VCP in misfolded protein degradation. VCP has a polyglutamine and ubiquitin-binding capacity and is involved in proteasomal degradation, cytosolic aggregation and processing of polyQ and polyUb aggregates in neurodegenerative and other misfolded protein diseases [9, 10]. Mutations in VCP gene are also linked to a protein deposition disorder, IBMFD [11]. We propose VCP as a therapeutic target for diseases caused by cytosolic protein aggregation or degradation of misfolded protein. We predict that selective interference of VCP interaction(s) with aberrant protein or its ERAD function will be an effective therapeutic site to rescue functional misfolded protein in diseases like cystic fibrosis and alpha-1-trypsin deficiency. The control of VCP expression is also proposed to be a potential therapeutic target in ex-polyQ-induced neurodegenerative diseases [12]. The further functional characterization of VCP and associated proteins in these diseases will help in designing of selective therapeutics.
authors.affiliation: Division of Pediatric Respiratory Sciences & Institute of NanoBioTechnology, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. nvij1@jhmi.edu
authors.forename: Neeraj
authors.initials: N
authors.lastname: Vij
mesh_terms: D000251:Adenosine Triphosphatases / Q000737:chemistry / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use*; D000818:Animals; D018797:Cell Cycle Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use*; D004721:Endoplasmic Reticulum / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008954:Models, Biological; D008967:Molecular Biology; D015394:Molecular Structure; D046912:Multiprotein Complexes; D017510:Protein Folding; D015398:Signal Transduction; D013312:Stress, Physiological; D000074405:Valosin Containing Protein
chemical_list: D018797:Cell Cycle Proteins; D046912:Multiprotein Complexes; D000251:Adenosine Triphosphatases; C000614178:VCP protein, human; D000074405:Valosin Containing Protein
references.citation: Nature. 1993 Sep 30;365(6445):459-62
references.pmid: 8413590
references.citation: Nat Cell Biol. 2005 Aug;7(8):766-72
references.pmid: 16056268
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14132-8
references.pmid: 16186510
references.citation: Biochem Soc Trans. 2008 Feb;36(Pt 1):105-8
references.pmid: 18208395
references.citation: Nat Cell Biol. 2001 Dec;3(12):1086-91
references.pmid: 11781570
references.citation: Mol Biol Cell. 2003 Jan;14(1):262-73
references.pmid: 12529442
references.citation: EMBO J. 2006 Jul 26;25(14):3357-66
references.pmid: 16810319
references.citation: Mol Cell Biol. 2002 Jan;22(2):626-34
references.pmid: 11756557
references.citation: Mol Biol Cell. 2008 Apr;19(4):1328-36
references.pmid: 18216283
references.citation: J Biol Chem. 1998 Feb 6;273(6):3562-73
references.pmid: 9452483
references.citation: Arch Biochem Biophys. 2007 Jun 1;462(1):62-73
references.pmid: 17493577
references.citation: Am J Respir Cell Mol Biol. 2008 Feb;38(2):176-84
references.pmid: 17709599
references.citation: Mol Cancer Ther. 2002 Dec;1(14):1243-53
references.pmid: 12516957
references.citation: Nature. 2001 Dec 6;414(6864):652-6
references.pmid: 11740563
references.citation: J Biol Chem. 2004 Dec 3;279(49):51376-85
references.pmid: 15456787
references.citation: Nature. 1997 Jul 3;388(6637):75-8
references.pmid: 9214505
references.citation: Cell. 1995 Sep 22;82(6):905-14
references.pmid: 7553851
references.citation: J Biol Chem. 2008 Aug 8;283(32):21926-33
references.pmid: 18508776
references.citation: Ann Surg Oncol. 2004 Feb;11(2):165-72
references.pmid: 14761919
references.citation: Am J Respir Crit Care Med. 2008 Oct 15;178(8):838-46
references.pmid: 18635891
references.citation: Mol Cell. 2005 Sep 16;19(6):829-40
references.pmid: 16168377
references.citation: Biochem Biophys Res Commun. 2006 Nov 3;349(4):1285-93
references.pmid: 16979136
references.citation: Mol Cell. 2006 May 19;22(4):451-62
references.pmid: 16713576
references.citation: Ann Surg Oncol. 2004 Jul;11(7):697-704
references.pmid: 15231524
references.citation: Clin Cancer Res. 2003 Jan;9(1):346-54
references.pmid: 12538487
references.citation: EMBO J. 2000 May 15;19(10):2181-92
references.pmid: 10811609
references.citation: Trends Genet. 1998 Oct;14(10):396-402
references.pmid: 9820028
references.citation: Cell Death Differ. 2002 Mar;9(3):264-73
references.pmid: 11859409
references.citation: Cell. 2006 Aug 11;126(3):571-82
references.pmid: 16901789
references.citation: Cell. 2003 Dec 12;115(6):727-38
references.pmid: 14675537
references.citation: J Biol Chem. 2007 Nov 23;282(47):33908-14
references.pmid: 17872946
references.citation: Nat Genet. 2004 Apr;36(4):377-81
references.pmid: 15034582
references.citation: Cell. 1998 Mar 6;92(5):603-10
references.pmid: 9506515
references.citation: Genes Cells. 2007 Jul;12(7):889-901
references.pmid: 17584300
references.citation: J Biol Chem. 2004 Oct 29;279(44):45676-84
references.pmid: 15331598
references.citation: Mol Cancer Ther. 2006 Sep;5(9):2251-60
references.pmid: 16985059
references.citation: Mol Biol Cell. 2000 Aug;11(8):2529-42
references.pmid: 10930451
references.citation: Trends Biochem Sci. 2001 Oct;26(10):619-24
references.pmid: 11590015
references.citation: Ann Neurol. 2005 Mar;57(3):457-61
references.pmid: 15732117
references.citation: Biochim Biophys Acta. 2008 Jul;1783(7):1418-35
references.pmid: 18284922
references.citation: J Biol Chem. 2006 Jun 23;281(25):17369-17378
references.pmid: 16621797
references.citation: Am J Respir Cell Mol Biol. 2007 Jun;36(6):706-14
references.pmid: 17272822
references.citation: Cell Death Differ. 2001 Oct;8(10):977-84
references.pmid: 11598795
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13637-42
references.pmid: 11087817
references.citation: J Biol Chem. 2005 Sep 9;280(36):31870-81
references.pmid: 16027165
references.citation: Cancer Res. 2006 Apr 1;66(7):3773-81
references.pmid: 16585204
references.citation: J Biochem. 2005 Feb;137(2):115-9
references.pmid: 15749824
references.citation: Jpn J Cancer Res. 2002 Mar;93(3):296-304
references.pmid: 11927012
references.citation: FEBS Lett. 2006 Jan 23;580(2):474-8
references.pmid: 16386250
references.citation: Mol Biol Cell. 2003 Oct;14(10):4221-9
references.pmid: 12937274
references.citation: EMBO Rep. 2001 May;2(5):423-30
references.pmid: 11375935
references.citation: Nat Cell Biol. 2001 Aug;3(8):740-4
references.pmid: 11483959
references.citation: Mol Biol Cell. 2004 Sep;15(9):4125-35
references.pmid: 15215312